Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 542

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Interventions to Improve Medication Adherence in Schizophrenia

Zygmunt, Annette, Olfson, Mark, Boyer, Carol A., Mechanic, David·2002·American Journal of Psychiatry

Abstract

OBJECTIVE: Although nonadherence with the antipsychotic medication regimen is a common barrier to the effective treatment for schizophrenia, knowledge is limited about how to improve medication adherence. This systematic literature review examined psychosocial interventions for improving medication adherence, focusing on promising initiatives, reasonable standards for conducting research in this area, and implications for clinical practice. METHOD: Studies were identified by computerized searches of MEDLINE and PsychLIT for the years between 1980 and 2000 and by manual searches of relevant bibliographies and conference proceedings. Key articles were summarized. RESULTS: Thirteen (33%) of 39 identified studies reported significant intervention effects. Although interventions and family therapy programs relying on psychoeducation were common in clinical practice, they were typically ineffective. Concrete problem solving or motivational techniques were common features of successful programs. Interventions targeted specifically to problems of nonadherence were more likely to be effective (55%) than were more broadly based treatment interventions (26%). One-half (four of eight) of the successful interventions not specifically focused on nonadherence involved an array of supportive and rehabilitative community-based services. CONCLUSIONS: Psychoeducational interventions without accompanying behavioral components and supportive services are not likely to be effective in improving medication adherence in schizophrenia. Models of community care such as assertive community treatment and interventions based on principles of motivational interviewing are promising. Providing patients with concrete instructions and problem-solving strategies, such as reminders, self-monitoring tools, cues, and reinforcements, is useful. Problems in adherence are recurring, and booster sessions are needed to reinforce and consolidate gains.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.159.10.1653

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 4 references

Research works printed but not linked: 65

  1. Thornley B, Adams C: Content and quality of 2000 controlled trials in schizophrenia over 50 years. Br Med J 1998; 317:1181-1184 · DOI · Paper page
  2. Babiker IE: Noncompliance in schizophrenia. Psychiatr Dev 1986; 4:329-337
  3. Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophr Bull 1995; 21:419-429 · DOI · Paper page
  4. Young JL, Spitz RT, Hillbrand M, Daneri G: Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments and prospects. J Am Acad Psychiatry Law 1999; 27:426-442 · doi:10.1177/009318539902700208
  5. Fenton WS, Blyler C, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997; 23:637-651 · DOI · Paper page
  6. Haynes RB, McKibbon KA, Kanani R: Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348:383-386 · DOI · Paper page
  7. Mojtabai R, Nicholson RA, Carpenter BN: Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies. Schizophr Bull 1998; 24:569-587 · DOI · Paper page
  8. Razali SM, Hasanah CI, Khan A, Subramaniam M: Psychosocial interventions for schizophrenia. J Ment Health 2000; 9:283-289 · DOI
  9. Strang JS, Falloon IR, Moss HB, Razani J, Boyd JL: The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacol Bull 1981; 17:87-88
  10. Guimon L, Eguiluz I, Bulbena A: Group pharmacotherapy in schizophrenics: attitudinal and clinical changes. Eur J Psychiatry 1993; 7:147-154
  11. Kelly GR, Scott JA: Medication compliance and health education among outpatients with chronic mental disorders. Med Care 1990; 28:1181-1197 · DOI
  12. Bush CT, Langford MW, Rosen P, Gott W: Operation outreach: intensive case management for severely psychiatrically disabled adults. Hosp Community Psychiatry 1990; 41:647-649 · DOI
  13. Sands RG, Cnaan RA: Two models of case management: assessing their impact. Community Ment Health J 1994; 30:441-457 · DOI
  14. Kemp R, Hayward P, Applewhaite G, Everitt B, David A: Compliance therapy in psychotic patients: randomised controlled trial. Br Med J 1996; 372:345-349 · DOI · Paper page
  15. Kemp R, Kirov G, Hayward P, David A: Randomized controlled trial of compliance therapy—18-month follow-up. Br J Psychiatry 1998; 172:413-419 · DOI · Paper page
  16. Azrin NH, Teichner G: Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther 1998; 36:849-861 · DOI
  17. Boczkowski JA, Zeichner A, DeSanto N: Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychiatry 1985; 53:666-671 · DOI
  18. Macpherson R, Jerrom B, Hughes A: A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry 1996; 168:709-717 · DOI
  19. Hornung WP, Kieserg A, Feldmann R, Buchkremer G: Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns 1996; 29:257-268 · DOI
  20. Hornung WP, Klingberg S, Feldmann R, Schonauer K, Schulze Monking H: Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand 1998; 97:213-219 · DOI
  21. Buchkremer G, Klingberg S, Holle R, Schulze Monking H, Hornung WP: Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up. Acta Psychiatr Scand 1997; 96:483-491 · DOI
  22. Seltzer A, Roncari I, Garfinkel P: Effect of patient education on medication compliance. Can J Psychiatry 1980; 25:638-645 · DOI · Paper page
  23. Battle EH, Halliburton A, Wallston KA: Self medication among psychiatric patients and adherence after discharge. J Psychosoc Nurs Ment Health Serv 1982; 20:21-28 · DOI
  24. Atkinson JM, Coia DA, Gilmour WH, Harper JP: The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry 1996; 168:199-204 · DOI
  25. Hogarty GE, Kornblith SJ, Greenwald D, DiBarry AL, Cooley S, Ulrich RF, Carter M, Flesher S: Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: description of study and effects on relapse rates. Am J Psychiatry 1997; 154:1504-1513 · DOI · Paper page
  26. Streicker SK, Amdur M, Dincin J: Educating patients about psychiatric medications: failure to enhance compliance. Psychosoc Rehabil J 1986; 4:15-28 · DOI
  27. Malm U: The influence of group therapy on schizophrenia. Acta Psychiatr Scand Suppl 1982; 297:1-65 · DOI
  28. Falloon IR, McGill CW, Boyd JL, Pederson J: Family management in the prevention of morbidity of schizophrenia. Arch Gen Psychiatry 1985; 42:887-896 · DOI · Paper page
  29. Glick ID, Clarkin JF, Haas GL, Spencer JH: A randomized clinical trial of inpatient family intervention, VI: mediating variables and outcome. Fam Process 1991; 30:85-99 · DOI
  30. Leff J, Kuipers L, Berkowitz R, Sturgeon D: A controlled trial of social interventions in the families of schizophrenia patients: two year follow-up. Br J Psychiatry 1985; 146:594-600 · DOI · Paper page
  31. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C: A trial of family therapy v a relatives group for schizophrenia. Br J Psychiatry 1989; 154:58-66 · DOI · Paper page
  32. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C: A trial of family therapy versus a relatives’ group for schizophrenia: two-year follow-up. Br J Psychiatry 1990; 157:571-577 · DOI · Paper page
  33. McFarlane WR, Lukens E, Link B, Dushay R, Deakins SA, Newmark M, Dunne EJ, Horen B, Toran J: Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995; 52:679-687 · DOI · Paper page
  34. Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, Hargreaves WA, Kane JM, Ninan PT, Frances A, Jacobs M, Lieberman JA, Mance R, Simpson GM, Woerner MG: Relapse and rehospitalization during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment. Arch Gen Psychiatry 1997; 54:453-463 · DOI · Paper page
  35. Tarrier N: The community management of schizophrenia: a controlled trial of a behavioral intervention with families to reduce relapse. Br J Psychiatry 1988; 153:532-542 · DOI · Paper page
  36. Telles C, Karno M, Mintz J, Paz G, Arias M, Tucker D, Lopez S: Immigrant families coping with schizophrenia: behavioral family intervention v case management with a low-income Spanish-speaking population. Br J Psychiatry 1995; 167:473-479 · DOI
  37. Xiong W, Phillips MR, Xiong H, Ruiwen W, Quinquing D, Kleinman J, Kleinman A: Family-based intervention for schizophrenic patients in China: a randomised controlled trial. Br J Psychiatry 1994; 165:239-247 · DOI · Paper page
  38. Zhang M, Wang M, Li J, Phillips MR: Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients: an 18-month study in Suzhou, Jiangsu. Br J Psychiatry Suppl 1994; 24:96-102 · DOI
  39. Teague GB, Bond GR, Drake RE: Program fidelity in assertive community treatment: development and use of a measure. Am J Orthopsychiatry 1998; 68:216-232 · DOI · Paper page
  40. Bond GR, Miller LD, Krumwied RD, Ward RS: Assertive case management in three CMHCs: a controlled study. Hosp Community Psychiatry 1988; 39:411-418 · DOI · Paper page
  41. Ford R, Beadsmore A, Ryan P, Repper J, Craig T, Muijen M: Providing the safety net: case management for people with serious mental illness. J Ment Health 1995; 1:91-97 · DOI
  42. Modrcin M, Rapp CA, Poertner J: The evaluation of case management services with the chronically mentally ill. Eval Program Plann 1988; 11:307-314 · DOI
  43. Solomon P, Draine J: The efficacy of a consumer case management team: 2-year outcomes of a randomized trial. J Ment Health Adm 1995; 22:135-146 · DOI
  44. Bigelow DA, McFarland BH, Gareau MJ, Young DJ: Implementation and effectiveness of a bed reduction project. Community Ment Health J 1991; 27:125-133 · DOI
  45. Bond GR, Witheridge TF, Wasmer D, Dincin J, McRae SA, Mayes J, Ward RS: A comparison of two crisis housing alternatives to psychiatric hospitalization. Hosp Community Psychiatry 1989; 40:177-183 · DOI
  46. Bond GR, McDonel EC, Miller LD, Pensec M: Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosoc Rehabil J 1991; 15:30-43 · DOI
  47. Dixon L, Weiden P, Torres M, Lehman A: Assertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry 1997; 154:1302-1304 · DOI
  48. Herz MI: Psychosocial treatment. Psychiatr Annals 1996; 26:531-535 · DOI
  49. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Javna CD, Madonia MJ: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, I: one-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 1986; 43:633-642 · DOI · Paper page
  50. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RJ, Carter M: Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry 1991; 48:340-347 · DOI · Paper page
  51. Linszen D, Dingemans P, Van Der Does JW, Nugter A, Scholte P, Lenior R, Goldstein MJ: Treatment, expressed emotion, and relapse in recent onset schizophrenic disorders. Psychol Med 1996; 26:333-342 · DOI · Paper page
  52. Merinder LB, Viuff AG, Laugesen HD, Clemmensen K, Misfelt S, Espensen B: Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol 1999; 34:287-294 · DOI
  53. Chan DW: Medication compliance in a Chinese psychiatric out-patient setting. Br J Med Psychol 1984; 57:81-89 · DOI
  54. Razali SM, Hasanah CI, Khan UA: Belief in supernatural causes of mental illness among Malay patients: impact on treatment. Acta Psychiatr Scand 1996; 94:221-223 · DOI · Paper page
  55. Perkins RE, Repper JM: Compliance or informed choice. Br J Ment Health 1999; 2:117-129 · DOI
  56. Zimmerman RS, Olson K: AIDS-related risk behavior and behavior change in a sexually active, heterosexual sample: a test of three models of prevention. AIDS Educ Prev 1994; 6:189-204
  57. Smith A, Mucklow JC, Wandless I: Compliance with drug treatment. Br Med J 1979; 1:1335-1336 · DOI
  58. Epstein LH, Cluss PA: A behavioral medicine perspective on adherence to long-term medical regimes. J Consult Clin Psychol 1982; 50:950-971 · DOI · Paper page
  59. Kelly KA: HIV risk reduction interventions for persons with severe mental illness. Clin Psychol Rev 1997; 17:293-309 · DOI
  60. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ: Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000; 51:216-222 · DOI · Paper page
  61. Marengo JT, Harrow M: Longitudinal courses of thought disorder in schizophrenia and schizoaffective disorder. Schizophr Bull 1997; 23:273-285 · doi:10.1093/schbul/23.2.273
  62. Cramer JA, Rosenheck R: Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis 1999; 187:53-55 · DOI
  63. Leucht S, Pitschel-Walz G, Abraham D, Kissling W: Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trials. Schizophr Res 1999; 35:51-68 · DOI · Paper page
  64. Rosenheck R, Chang S, Choe Y, Cramer J, Xu W, Thomas J, Henderson W, Charney D: Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol. J Clin Psychiatry 2000; 61:382-386 · DOI
  65. Dolder CR, Lacro JP, Dunn LB, Jeste DV: Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002; 159:103-108 · DOI · Paper page

Cited by

See all 542

Metadata

Authors
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D.
Venue
American Journal of Psychiatry
Published
2002-10-01
Volume
159
Issue
10
Pages
1653-1664
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2158206968
Cited by
542
References
4
FWCI
12.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interventions to Improve Medication Adherence in Schizophrenia. https://app.cochat.ai/papers/10.1176/appi.ajp.159.10.1653
The paper
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to Improve Medication Adherence in Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.159.10.1653

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.